Avecho Biotechnology Limited's market cap is currently ―. The company's EPS TTM is AU$; its P/E ratio is ―; Avecho Biotechnology Limited is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 1.47M	AU$ 3.26M	AU$ 1.87M	AU$ 3.21M	AU$ 2.11M
Total Assets	AU$ 3.35M	AU$ 5.25M	AU$ 3.35M	AU$ 5.32M	AU$ 4.80M
Total Debt	AU$ 246.07K	AU$ 93.91K	AU$ 166.23K	AU$ 97.19K	AU$ 0.00
Net Debt	AU$ -1.22M	AU$ -3.17M	AU$ -1.71M	AU$ -3.11M	AU$ -2.11M
Total Liabilities	AU$ 920.66K	AU$ 709.36K	AU$ 700.17K	AU$ 556.13K	AU$ 902.04K
Stockholders Equity	AU$ 2.42M	AU$ 4.54M	AU$ 2.65M	AU$ 4.76M	AU$ 3.90M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Income Statement >

Avecho Biotechnology Limited Debt to Assets

Balance Sheet >

Avecho Biotechnology Limited Cash Flow

Cash Flow >

Avecho Biotechnology Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing